How gut microbes affect blueberry polyphenol metabolites in healthy adults
Official title: Influence of the Gut Microbiome on Blueberry Polyphenol Metabolites
Run by Colorado State University · NCT07607158 · Data updated 2026-11-12
This study tests whether differences in the gut microbiome change how healthy adults metabolize blueberry polyphenols after a single blueberry dose.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 125 (estimated) |
| Sponsor | Colorado State University Academic / other |
| Locations | 1 site (Fort Collins, Colorado) |
| Status | Recruiting |
| Started | January 27, 2026 |
| Main results expected | March 1, 2027 |
| Study ends | January 1, 2028 |
| Registry record updated | May 26, 2026 |
| Trial ID | NCT07607158 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Healthy adults 18 years or older who can provide informed consent and are willing to follow study procedures.
✕Probably not a fit
Individuals with chronic diseases, recent antibiotic use, pregnancy, BMI ≤18.5, or conditions affecting nutrient absorption may not experience identified benefits.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This is an acute, single-arm pharmacokinetic study conducted at Colorado State University to explore how individual gut microbiomes shape the metabolism of blueberry polyphenols. Approximately 125 healthy adults will ingest a freeze-dried blueberry powder beverage, with blood and possibly other samples collected on a test day and a 24-hour follow-up to assess metabolite exposure. Participants will be stratified into metabotypes based on metabolite profiles and then analyzed with multi-omic approaches to see if the gut microbiome predicts these metabotypes. The study includes screening, an acute test day, and a follow-up visit, with careful eligibility criteria to exclude factors that could confound metabolism. Outcomes focus on pharmacokinetics of blueberry polyphenol metabolites and correlations with gut microbiome composition.
Why it matters
Potential benefit: If successful, findings could improve understanding of how gut microbiota influence nutrient metabolism and inform personalized nutrition strategies involving polyphenol-rich foods.
How similar studies have gone: Prior polyphenol pharmacokinetic studies have shown microbiome-related variability, supporting feasibility of this metabotype-driven approach.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Healthy adults ≥18 years of age * Able and willing to provide informed consent * Willing and able to adhere to all study procedures and visit requirements Exclusion Criteria: * Age \<18 years * Pregnant or breastfeeding * Presence of chronic diseases, including but not limited to cardiovascular disease, diabetes, cancer, kidney, liver, gastrointestinal, or pancreatic disease * Use of medications for chronic diseases that may interfere with study outcomes * Any condition known to negatively impact nutrient absorption (e.g., inflammatory bowel disease, celiac disease, gastroparesis) * Anemia (hemoglobin \<13.5 g/dL in men or \<12.0 g/dL in women) * Body mass index (BMI) ≤18.5 kg/m² * Use of antibiotics within the past 2 months * Recent blood draw within 1 week prior to study participation * Currently participating in another research study involving a diet or exercise intervention * Known allergy or contraindication to blueberry products or study procedures * Unwilling or unable to comply with study requirements
Where it's running
-
Colorado State University; Food and Nutrition Clinical Research Laboratory; Gifford Building Room 216; 502 West Lake Street, Fort Collins, CO 80523
Fort Collins, Colorado, United States Recruiting
Study contacts
- Study coordinator: Tiffany Weir, PhD
- Email: tiffany.weir@colostate.edu
- Phone: (970) 491-4631
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Barley and kefir to support gut health in active adults
This study tests whether a daily barley and kefir meal for four weeks can change gut microbiota in physically active adults and whether those changes relate to certain metabolites in blood and urine.
-
Virtual approaches for period pain in young women
This study tests two online self-care options—auricular acupressure and Baduanjin qigong—against a self-care education group to see if they reduce menstrual pain and related symptoms in young women.
-
Brain and metabolic responses to different macronutrients in people with obesity
This trial will test whether three small, isocaloric liquid meals (glucose, fat, or protein) change brain activity and blood metabolites in adults with obesity and healthy-weight adults.
-
Scalp hair chemical changes in people with severe obesity and after bariatric surgery
This project will see if chemicals trapped in scalp hair change with body weight and can signal hair thinning or muscle loss in adults having bariatric surgery.
-
Epilepsy and gut and mouth bacteria: linking microbiota to seizure medicine response
This project will test whether differences in gut and mouth bacteria are linked to epilepsy type and change how well seizure medicines work in people newly diagnosed with epilepsy compared with healthy volunteers.
-
Omega-3 supplements added to standard TB treatment in adults with pulmonary TB
This trial tests whether adding omega-3 EPA and DHA to standard TB therapy for 8 weeks helps kill the bacteria faster and reduce inflammation in adults with new, drug-sensitive pulmonary TB.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.